The Food and Drug Administration is trying to curb the rampant abuse of acetaminophen by asking doctors to quit prescribing drugs that combine medications with more than 325 milligrams of acetaminophen per pill.
Recall-plagued Johnson & Johnson is pulling all infant Tylenol off the U.S. market because some parents have had problems with redesigned bottles, introduced three months ago, that the company touted as a big safety improvement to make measuring doses easier.
If you’ve picked up a bottle of Extra Strength Tylenol and noticed a musty or moldy odor, you’re not alone. Johnson & Johnson, makers of Tylenol, issued a recall of nearly 61,000 bottles of the medication.
Federal health experts said Wednesday that dosing instructions for children younger than 2 years old should be added to Children’s Tylenol and similar products containing acetaminophen, the popular pain reliever and fever reducer.
Complaints of a musty smell has spawned a recall of thousands of bottles of Tylenol.
Federal officials said Thursday that the consumer health unit of Johnson & Johnson will be barred from resuming operations at a Pennsylvania manufacturing plant linked to millions of bottles of defective medicines until it meets quality standards.
Johnson & Johnson has recalled 47 million packages of Tylenol, Sudafed and other nonprescription drugs manufactured at a Pennsylvania facility.